The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistance

Overview of attention for article published in Frontiers in immunology, December 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (73rd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 60,206 followers.

RT @FrontImmunol: New Research: The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival an…

RT @moreauxjerome: Happy to share the last publication of the group in collaboration with @PaseroLab and @ConstantinouL: 🙏🏻 #mmsm @IGH_MTP…

RT @moreauxjerome: Happy to share the last publication of the group in collaboration with @PaseroLab and @ConstantinouL: 🙏🏻 #mmsm @IGH_MTP…

RT @moreauxjerome: Happy to share the last publication of the group in collaboration with @PaseroLab and @ConstantinouL: 🙏🏻 #mmsm @IGH_MTP…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.